ReviewFrontiers in genetics2020

Targeting Cancer Stem Cells by Genetically Engineered Chimeric Antigen Receptor T Cells.

Rowa Y AlhabbabPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.